EL
ELV
Quarter ended Dec 31, 2023 · FY2023 Q4

Elevance Health (ELV) Revenue — Quarter Ended Dec 31, 2023

Revenue for the quarter declined compared to the immediately preceding quarter. However, it rose compared to the same quarter one year earlier.

Key takeaway

Quarter ended Dec 31, 2023 · FY2023 Q4

Revenue for the quarter declined compared to the immediately preceding quarter. However, it rose compared to the same quarter one year earlier.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$42.6B

Revenue reported for this quarter.

Quarter-over-quarter

-0.5%

Change from the immediately preceding quarter.

Year-over-year

+6.8%

Change from the comparable year-ago quarter.

Trailing four quarters

$171.3B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Mar 31, 2023$42.2B+10.7%
Jun 30, 2023$43.7B+13.0%
Sep 30, 2023$42.8B+7.3%
Dec 31, 2023$42.6B+6.8%

Revenue performance

The reported revenue direction is down from the prior quarter, continuing a sequence of fluctuating quarterly figures.

Quarterly comparison

Compared with the immediately preceding quarter, revenue decreased. Versus the same quarter one year earlier, revenue increased.

What to watch

Revenue in the most recent quarter reversed the upward trend seen in the prior sequential quarter.